13FPulse
中
BC

BCRX BIOCRYST PHARMACEUTICALS INC

2026Q2 · CUSIP 09058V103 · Sector: Healthcare & Biotech

Cooling

Net holder growth weakened from last quarter

Funds that own it
314
Institutions that reported holding it to the SEC
Net increase in holders
+16
Last quarter 298 → now 314
How unusual is that
Above average
Stronger buying than 79% of US stocks
What the filings say, in one paragraph

314 funds held BCRX at the end of 2026Q2, up 16 from the quarter before. Buying has come off its highs, but funds are not exiting. On the business itself, revenue over the last 12 months was $941M(YoY +68.7%). BCRX has had 10 buying rushes in its history, and the price moved -10.9% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2013Q3: holders=71 2013Q4: holders=73 2014Q1: holders=85 2014Q2: holders=99 2014Q3: holders=102 2014Q4: holders=90 2015Q1: holders=97 2015Q2: holders=122 2015Q3: holders=123 2015Q4: holders=118 2016Q1: holders=109 2016Q2: holders=101 2016Q3: holders=103 2016Q4: holders=111 2017Q1: holders=117 2017Q2: holders=114 2017Q3: holders=119 2017Q4: holders=115 2018Q1: holders=102 2018Q2: holders=102 2018Q3: holders=116 2018Q4: holders=122 2019Q1: holders=130 2019Q2: holders=112 2019Q3: holders=113 2019Q4: holders=135 2020Q1: holders=132 2020Q2: holders=162 2020Q3: holders=151 2020Q4: holders=176 2021Q1: holders=190 2021Q2: holders=193 2021Q3: holders=194 2021Q4: holders=205 2022Q1: holders=231 2022Q2: holders=219 2022Q3: holders=231 2022Q4: holders=230 2023Q1: holders=241 2023Q2: holders=233 2023Q3: holders=229 2023Q4: holders=232 2024Q1: holders=234 2024Q2: holders=239 2024Q3: holders=254 2024Q4: holders=257 2025Q1: holders=272 2025Q2: holders=293 2025Q3: holders=286 2025Q4: holders=272 2026Q1: holders=298 2026Q2: holders=314 -30 -15 +0 +15 +30 63197330 13Q315Q116Q318Q119Q321Q122Q324Q125Q326Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 10 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2026Q1 Top 20% — —
2025Q2 Top 20% -15.5% -13.4%
2025Q1 Top 20% -20.2% -32.2%
2023Q1 Top 20% -17.4% -38.5%
2022Q3 Top 20% -20.9% -34.5%
2022Q1 Top 10% +68.2% +51.3%
2020Q2 Top 20% -2.6% +135.3%
2018Q3 Top 20% +10.5% -56.3%
2015Q2 Top 10% -21.0% -82.2%
2014Q2 Top 20% -27.6% -27.3%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
167
Change in large funds
+17
Total value they hold
$2.6B
Funds buying for the first time
58
Funds that sold out entirely
42
Price change that quarter
+13.4%
Funds holding puts (bearish)
6
Funds holding calls (bullish)
8

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
—
EPS (TTM)
$-1.49
EPS YoY
—
Revenue (TTM)
$0.9B
Revenue YoY
+68.7%
Net margin
-40.9%
ROE
—
Debt ratio
—
FCF (TTM)
$373M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2021-09-30: EPS -0.33 2021-12-31: EPS -0.10 2022-03-31: EPS -0.40 2022-06-30: EPS -0.32 2022-09-30: EPS -0.23 2022-12-31: EPS -0.38 2023-03-31: EPS -0.28 2023-06-30: EPS -0.40 2023-09-30: EPS -0.19 2023-12-31: EPS -0.31 2024-03-31: EPS -0.17 2024-06-30: EPS -0.06 2024-09-30: EPS -0.07 2024-12-31: EPS -0.13 2025-03-31: EPS 0.00 2025-06-30: EPS 0.02 2025-09-30: EPS 0.06 2025-12-31: EPS 1.13 2026-03-31: EPS -2.98 2026-06-30: EPS 0.30 0M 203M 407M $M -3.28 -1.02 1.24 2016201720182019202020212022202320242025202606/26 Revenue EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
5 5 6 20252026

P/E = close around day 47 after quarter-end ÷ TTM EPS then; this is a consistent valuation date, not the company’s actual filing date; loss quarters hidden

Quarterly free cash flow
-78M106M291M 20162017201820192020202120222023202420252026
Latest quarter $-62M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.